BioSpace News Archive

Policy

Ablexis Announces Progress in Its Intellectual Property on AlivaMab Mouse and Immunoglobulin Locus Engineering

Issued claims cover unique features of AlivaMab Mouse, AlivaMab antibodies and immunoglobulin transgene construction and compositions

November 13, 2018
·
2 min read
Drug Development

Syros Presents New Preclinical Combination Data on SY-1365 and First Preclinical Data from Oral CDK7 Inhibitor Program at EORTC-NCI-AACR Meeting

SY-1365 Shows Synergistic Anti-Tumor Activity in Combination with Carboplatin in Preclinical Models of Ovarian Cancer.

November 13, 2018
·
7 min read
Business

Agilvax Appoints Joseph Patti, Ph.D. as Executive Chairman

Adds significant drug and business development experience to Agilvax as it transitions into a clinical stage company

November 13, 2018
·
2 min read
Business

Aridis Pharmaceuticals Announces Third Quarter 2018 Financial Results and Corporate Overview

Completed an initial public offering on August 16 and began trading on the Nasdaq Capital Market

November 13, 2018
·
17 min read
Business

Tiger Group and Liquidity Services Launch ‘Powerhouse Partnership’ Focused on Distressed Assets in Biopharma

--Newly formed Tiger Liquidity Services Biopharma Partners broadens options for turnaround and insolvency professionals working in the sector

November 13, 2018
·
3 min read
Business

ProMIS Neurosciences Announces Third Quarter 2018 Results

ProMIS Neurosciences, Inc. today announced its operational and financial results for the three and nine months ended September 30, 2018.

November 13, 2018
·
7 min read
Business

BIONIK Laboratories Second Quarter Fiscal 2019 Financial Results Feature 147% Increase in Revenues

BIONIK Laboratories Corp. today announced financial results for the second quarter of fiscal year 2019, ended September 30, 2018.

November 13, 2018
·
14 min read
Business

CANbridge Appoints Vice President of Finance and Controller and Vice President of China Oncology and Business Unit Head

CANbridge Pharmaceutical Inc. announced that it appointed Jeff Lau as Vice President of Finance and Controller, effective September 10th, and Fangzhou Cheng, as Vice President of China Oncology and Business Unit Head, effective October 29th.

November 13, 2018
·
3 min read
Business

Catabasis Pharmaceuticals Announces Collaboration with the University of Texas Southwestern to Explore the Potential Benefits of Edasalonexent on Cardiac Function in Duchenne and Becker Muscular Dystrophies

One-Year Preclinical Study of Edasalonexent, a Novel Inhibitor of NF-kB, in Animal Models of Duchenne to Investigate Potential Improved Cardiac Function

November 13, 2018
·
7 min read
BioCapital

AsclepiX Therapeutics Raises $5M in New Funding

Financing will advance clinical development of the Company’s lead product AXT107

November 13, 2018
·
4 min read